Drug intelligence / Profile preview

Vipalbumin Junior

Development stage: Unknown
Lead developer: Royal Medicalink Pharmalab
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

Vipalbumin Junior (also marketed as VipAlbumin Plus Junior) is an oral pediatric nutraceutical supplement developed by Royal Medicalink Pharmalab. It is formulated as a sachet containing a combination of snakehead fish extract (*Ophiocephalus striatus* or *Channa striata*) and turmeric extract (*Curcuma domestica* rhizome). The supplement is designed to support pediatric nutrition, address stunting and malnutrition, increase serum albumin levels, and promote wound healing in children. The *Ophiocephalus striatus* extract provides a rich source of albumin, essential amino acids, and fatty acids that aid in tissue regeneration and immune support, while the *Curcuma domestica* extract helps improve appetite and offers anti-inflammatory benefits.

Brand names: VipAlbumin JuniorVipAlbumin Junior PlusVipAlbumin Plus Junior
Other names: Channa striata extract + Curcuma domestica rhizoma extractOphiocephalus striatus extract + Curcuma domestica rhizoma extract

Beyond the preview

Go deeper on Vipalbumin Junior.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vipalbumin Junior.

Explore the full profile